With the recent completion of Series A funding, resulting in $3 million in raised capital, Tokyo Smoke will release four branded cannabis strains in the first quarter of 2017 in collaboration with Aphria Inc ("Aphria"), one of Canada's largest licensed producers of medical marijuana.